Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites

A. Garofalo, M. Valle, J. Garcia, P. H. Sugarbaker

Research output: Contribution to journalArticlepeer-review


Aim: To report the use of laparoscopic Intraperitoneal Hyperthermic Chemotherapy (LIPHC) in the treatment of malignant ascites. Methods: From September 2001 to December 2003, 14 patients between the age of 56 and 78 years were treated. Ascites was from gastric cancer (5 cases), colorectal cancer (3 cases), ovarian cancer (3 cases), breast cancer (2 cases) and peritoneal mesothelioma (1 case). The LIPHC was carried out at 42 °C for 90 min with 1.5% dextrose solution as a carrier. Chemotherapy was cisplatin and doxorubicin or mitomycin depending on the type of primary tumor. The drains were left in situ after surgery and removed when perfuse drainage ceased. Results: Ascites was controlled in all the treated cases. A CT scan performed in follow-up showed a small, clinically undetectable, fluid accumulation in the pelvis of one patient. Conclusions: This method resulted in benefit for those peritoneal carcinomatosis patients with debilitating malignant ascites who were excluded from cytoreductive surgery. Proficiency in laparoscopic staging procedures and experience in the management of carcinomatosis and intraperitoneal hyperthermic chemotherapy (IPHC) are required for the success of the procedure.

Original languageEnglish
Pages (from-to)682-685
Number of pages4
JournalEuropean Journal of Surgical Oncology
Issue number6
Publication statusPublished - Aug 2006


  • Carcinomatosis
  • Cisplatin
  • Doxorubicin
  • Hyperthermia
  • Intraperitoneal chemotherapy
  • Laparoscopy

ASJC Scopus subject areas

  • Oncology
  • Surgery


Dive into the research topics of 'Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites'. Together they form a unique fingerprint.

Cite this